U.S. stock futures started Friday on a modestly positive note, with the S&P 500 futures climbing around 0.1%. But not every company was enjoying the morning optimism.
WD-40 Co (WDFC) took a beating in pre-market trading after delivering first-quarter results that missed the mark on both the top and bottom lines. The company famous for that little blue and yellow can reported earnings of $1.28 per share, falling short of the $1.36 consensus estimate analysts had penciled in. Revenue came in at $154.423 million, also below the expected $155.085 million. Investors weren't thrilled with the miss, sending shares down 9.1% to $185.00 before the opening bell.
WD-40 wasn't alone in the pre-market red zone. Here's a look at other stocks sliding lower Friday morning.
Beta Bionics Inc (BBNX) dropped 15.6% to $27.00 after releasing preliminary fourth-quarter financial results that apparently didn't sit well with traders.
Olin Corp (OLN) suffered the steepest decline, falling 11.7% to $19.92. The chemical manufacturer dramatically cut its fourth-quarter adjusted EBITDA outlook to about $67 million, well below its previous guidance range of $110 million to $130 million. That's the kind of downward revision that makes investors hit the sell button.
AXT Inc (AXTI) declined 10.3% to $23.12 following an update to its fourth-quarter revenue expectations, suggesting the numbers won't be as strong as previously thought.
Aclarion Inc (ACON) tumbled 7% to $7.60, giving back some of Thursday's impressive gains. The stock had surged 42% the previous day after reporting that quarterly Nociscan scan volumes jumped 114% year over year.
iHeartMedia, Inc (IHRT) dipped 4.3% to $3.81 in pre-market action.
Coincheck Group N.V. (CNCK) fell 3.9% to $2.70. On Thursday, the company announced an agreement to acquire 3iQ, though the market seems to be taking a cautious stance on the deal.
Neogen Corporation (NEOG) slipped 3.1% to $9.40, also paring back Thursday's gains. The stock had rocketed around 32% higher the previous day after beating second-quarter expectations and raising its fiscal 2026 sales guidance above analyst estimates.
General Motors Company (GM) edged down 1.9% to $83.50 after disclosing it will take approximately $7.1 billion in fourth-quarter charges related to electric vehicle impairments, China restructuring costs, and legal expenses. That's a hefty number that's bound to weigh on the quarter's results.
